Mark Lanier Honored Twice by National Law Journal

Legal Publication Declares Houston Lawyer One of 100 Most Influential Lawyers, 10 Winning Trial Lawyers

(Houston) Mark Lanier, founder of The Lanier Law Firm, has been named one of the country's 100 Most Influential Lawyers, as well as one of 10 Winning Trial Lawyers by the prestigious National Law Journal.

The "Winning" designation was published in the NLJ's June 5 edition, and the "Most Influential" list was published in its June 19 edition.

In its selection, the publication cited two recent verdicts one for $253 million and one for $13.5 million_against Merck & Co., the maker of VIOXX®. The arthritis medication was taken off the market in 2004 because of links to heart failure.

The NLJ called Lanier "a Texan with a competitive streak as big as the Lone Star State" and said he "looks for an edge wherever he can find it."

"When closing the New Jersey (VIOXX®) trial, he described the case like several episodes of the primetime soap Desperate Housewives, complete with a chart," the NLJ reported.

Lanier told the NLJ he's not trying to be "theatrical" (as his opponents sometime claim). He's just trying to connect with jurors. "If you tell stories, jurors will remember it better, and relate to it better," Lanier told the NLJ.

Lisa Blue, a close friend of Lanier's, praised his style. "He is passionate. He's funny without being inappropriate, and the whole time he's trying a case, it's as if he's just having a conversation," she said. "He talks to a witness as if he's talking to a friend at a cocktail party. It's a very relaxed and real style for him."

In selecting its list of the 100 Most Influential Lawyers in America, editors focused on "attorneys outside the government with the clout to make big things happen."

In selecting its list of 10 Winning trial lawyers, the NLJ set out the following criteria: that nominees have at least one significant win--either bench or trial--within the last 18 months, and a track record of significant wins over many years. Other factors that piqued the publication's interest were instances where a win altered case precedent or occurred in a hostile jurisdiction.

For more information please contact The Lanier Law Firm.

PDF
Print

Law Firm News

Vioxx Settlement Update

Information for Vioxx clients awaiting information on claims package approval.


Chantix Side Effects

The FDA recently stated that "Serious neuropsychiatric symptoms have occurred in patients taking Chantix." A more recent study indicates other side effects including heart trouble, seizures and diabetes.


Consumer Advocacy Award

The Massachusetts Academy of Trial Attorneys honors Mark Lanier based on his work for injured individuals across the United States. 


Vytorin and Zetia

A recent clinical study showed the cholesterol-lowering drugs Vytorin and Zetia may not work at all.


Trasylol Studies

Studies say Trasylol patients have increased risk of kidney damage, heart attacks and strokes.


Medtronic Recall

The FDA announced a nationwide recall for implantable fusion pumps manufactured by Medtronic Neuromodulation.


Law Firm Recognized

Lanier recognized as one of 'Best Lawyers in America' and one of America's Top Plaintiff's Lawyers.


Heparin Recall

There has been a recent, nationwide recall of Heparin Sodium USP.


Pharmaceutical Liability

Read about: Fosamax; ReNu with MoistureLoc contact lens solution; Zicam nasal gel; Ketek antibiotic; Composix Kugel Mesh Patch; and Avandia.

Law Firm Locations: Houston Law Firm | New York Law Firm | Los Angeles Law Firm | Palo Alto Law Firm
© 2008 The Lanier Law Firm. All rights reserved. Disclaimer: Client's rights and responsibilities.
Past results do not guarantee similar outcomes in future cases.
Contact The Lanier Law Firm for more information.
Attorney Advertising